Group 1 - Elastic (ESTC) closed at $82.69, with a 2.3% gain over the past four weeks, and a mean price target of $112.17 suggests a 35.7% upside potential [1] - The average of 24 short-term price targets ranges from a low of $75.00 to a high of $148.00, with a standard deviation of $15.45, indicating variability among analysts [2] - Analysts show strong agreement in revising EPS estimates higher, which correlates with potential stock price movements [11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 68.8% over the past month, with nine estimates going higher and two lower [12] - ESTC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting gains, they can indicate the direction of price movement [14]

分组1 - Vigil Neuroscience, Inc. (VIGL) closed at $7.93, with a 0.6% gain over the past four weeks, and a mean price target of $10 indicates a 26.1% upside potential [1] - The average price targets from analysts range from a low of $8.00 to a high of $22.00, with a standard deviation of $5.29, suggesting variability in estimates [2] - Analysts show strong agreement on VIGL's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] 分组2 - Recent revisions in earnings estimates for VIGL have been positive, with one estimate moving higher and the Zacks Consensus Estimate increasing by 2.6% [12] - VIGL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does provide a directional guide for price movement [14]

Core Viewpoint - Consensus Cloud Solutions, Inc. (CCSI) shows potential for upside with a mean price target of $27.4, indicating a 25.1% increase from the current price of $21.91 [1] Price Targets - The average price target consists of five estimates ranging from a low of $20.00 to a high of $37.00, with a standard deviation of $7.06, suggesting variability in analyst predictions [2] - The lowest estimate indicates a potential decline of 8.7%, while the highest suggests a 68.9% upside [2] Analyst Sentiment - Analysts are optimistic about CCSI's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.4%, with one estimate moving higher and no negative revisions [12] Zacks Rank - CCSI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, they should be approached with skepticism as they can mislead investors; analysts often set overly optimistic targets due to business incentives [7][8][10]

Core Viewpoint - Oric Pharmaceuticals, Inc. (ORIC) has seen a significant stock price increase of 57.1% over the past four weeks, closing at $9.22, with analysts suggesting a potential upside of 105% based on a mean price target of $18.9 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $4.04, indicating variability among analysts [2]. - The lowest price target is $12.00, suggesting a 30.2% increase from the current price, while the highest target is $25.00, indicating a potential surge of 171.2% [2]. - A low standard deviation signifies a strong agreement among analysts regarding the stock's price movement [9]. Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [11]. - Over the last 30 days, two earnings estimates for ORIC have been revised upward, leading to a 7.8% increase in the Zacks Consensus Estimate [12]. - ORIC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction indicated by these targets appears to be a useful guide for potential price movement [14].

Core Viewpoint - Qifu Technology, Inc. (QFIN) shows potential for upside with a mean price target of $54.8, indicating a 27.3% increase from the current price of $43.06 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $4.14, suggesting a consensus among analysts [2] - The lowest estimate is $50.00, indicating a 16.1% increase, while the highest estimate is $58.50, suggesting a 35.9% increase [2] - Analysts' price targets should be approached with caution, as their reliability has been questioned [3][7] Earnings Estimates and Analyst Agreement - Strong agreement among analysts regarding QFIN's earnings prospects supports the potential for stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 2.3% over the past month, with two estimates revised upward [12] - QFIN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]

Core Viewpoint - NCR Voyix (VYX) shares have increased by 6.2% over the past four weeks, closing at $11.56, with a mean price target of $14.63 indicating a potential upside of 26.6% [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $2.33, where the lowest estimate is $11 (4.8% decline) and the highest is $18 (55.7% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 7.1% over the past month, with one estimate increasing and no negative revisions [12] Zacks Rank and Investment Potential - VYX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate potential price movement direction [13]

Core Viewpoint - Instil Bio, Inc. (TIL) has shown significant stock price appreciation of 134% over the past four weeks, with analysts projecting a mean price target of $118.67, indicating a potential upside of 246.7% from the current price of $34.23 [1] Price Targets and Analyst Consensus - The average price target for TIL ranges from a low of $51 to a high of $180, with a standard deviation of $64.73, suggesting variability in analyst estimates [2] - The lowest estimate indicates a 49% increase, while the highest suggests a 425.9% upside, highlighting the potential for significant price movement [2] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about TIL's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which correlates with potential stock price increases [11] - Over the past 30 days, one earnings estimate has increased, leading to a 7.2% rise in the Zacks Consensus Estimate for the current year [12] - TIL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]

Core Viewpoint - American Superconductor (AMSC) shares have increased by 24.3% in the past four weeks, closing at $29.23, with a mean price target of $39 indicating a potential upside of 33.4% [1] Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $1, where the lowest estimate of $38 suggests a 30% increase, and the highest estimate of $40 indicates a 36.9% increase from the current price [2] - A low standard deviation signifies strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [7] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about AMSC's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which correlates with potential stock price movements [9] - The Zacks Consensus Estimate for the current year has risen by 2.5% over the past month, with two estimates increasing and no negative revisions [10] Zacks Rank and Investment Potential - AMSC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [11]

Core Viewpoint - QXO, Inc. shows significant potential for upside, with a mean price target of $34.33 indicating a 70.8% increase from the current trading price of $20.10, which has already gained 23.5% over the past four weeks [1]. Price Targets and Analyst Consensus - The average price target for QXO ranges from a low of $27 to a high of $44, with a standard deviation of $8.74, suggesting variability in analyst estimates. The lowest estimate indicates a 34.3% increase, while the highest suggests an 118.9% upside [2]. - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism regarding QXO's earnings prospects, as evidenced by a positive trend in earnings estimate revisions. This trend has a strong correlation with near-term stock price movements [11]. - Over the last 30 days, one earnings estimate for QXO has increased, leading to a Zacks Consensus Estimate rise of 391.7% [12]. Zacks Rank and Investment Potential - QXO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside in the near term [13].

Group 1 - DigitalBridge (DBRG) shares have increased by 11.8% over the past four weeks, closing at $10.63, with a mean price target of $16.65 indicating a potential upside of 56.6% [1] - The mean estimate consists of 10 short-term price targets with a standard deviation of $2.71, where the lowest estimate is $10.50 (1.2% decline) and the highest is $20 (88.2% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 26.9% over the past month [11][12] Group 2 - The Zacks Rank for DBRG is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While price targets are often viewed as a key metric, they can mislead investors, and analysts may set overly optimistic targets due to business incentives [7][8] - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price movement, serving as a starting point for further research [9]